Lexicon Pharmaceuticals, Inc. (LXRX)

NASDAQ: LXRX · Real-Time Price · USD

1.780

+0.170 (10.56%)

At close: Nov 6, 2026, 4:00 PM EST

1.780

0.00 (0.00%)

After-hours: Nov 6, 2026, 7:59 PM EST

Lexicon Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	38.54	49.8	31.08	1.2	0.14	0.3
Revenue Growth	-45.62%	60.24%	2481.48%	766.19%	-53.36%	-98.76%
Cost of Revenue	6.72	6.56	6.46	5.22	52.52	55.05
Gross Profit	31.82	43.24	24.63	-4.02	-52.38	-54.75
Selling, General & Admin	37.2	37.32	143.1	113.98	48.08	32.34
Research & Development	51.43	54.83	77.54	53.75	-	-
Operating Expenses	88.63	92.15	220.64	167.73	48.08	32.34
Operating Income	-56.81	-48.91	-196.02	-171.75	-100.46	-87.09
Interest Expense	-7.36	-8.34	-15.58	-13.1	-2.78	-0.8
Interest & Investment Income	6.91	6.91	12.29	7.73	1.6	0.13
EBT Excluding Unusual Items	-58	-50.34	-199.3	-177.12	-101.64	-87.76
Other Unusual Items	-4.35	-	-1.1	-	-0.3	-
Pretax Income	-62.35	-50.34	-200.4	-177.12	-101.94	-87.76
Net Income	-62.35	-50.34	-200.4	-177.12	-101.94	-87.76
Net Income to Common	-62.35	-50.34	-200.4	-177.12	-101.94	-87.76
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	412	363	320	221	166	146
Shares Outstanding (Diluted)	412	363	320	221	166	146
Shares Change	13.53%	13.44%	44.73%	33.42%	13.79%	31.41%
EPS (Basic)	-0.15	-0.14	-0.63	-0.80	-0.62	-0.60
EPS (Diluted)	-0.15	-0.14	-0.63	-0.80	-0.62	-0.60
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-	-67.85	-179.81	-162.37	-90.18	-88.24
Free Cash Flow Per Share	-	-0.19	-0.56	-0.73	-0.54	-0.61
Gross Margin	82.57%	86.82%	79.23%	-	-	-
Operating Margin	-147.42%	-98.21%	-630.67%	-14264.95%	-72273.38%	-29224.83%
Profit Margin	-161.80%	-101.08%	-644.78%	-14710.88%	-73341.01%	-29448.99%
Free Cash Flow Margin	-	-136.24%	-578.52%	-13485.63%	-64875.54%	-29610.07%
EBITDA	-56.39	-48.29	-195.48	-171.2	-100.03	-86.8
EBITDA Margin	-146.32%	-96.96%	-	-	-	-
D&A For EBITDA	0.42	0.62	0.53	0.55	0.43	0.29
EBIT	-56.81	-48.91	-196.02	-171.75	-100.46	-87.09
EBIT Margin	-147.42%	-98.21%	-	-	-	-
Revenue as Reported	38.54	49.8	31.08	1.2	0.14	0.3

SEC Filings: 10-K · 10-Q